Picture of Bon Natural Life logo

BON Bon Natural Life Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Momentum

Relative Strength (%)
1m-32.64%
3m-51.59%
6m-66.58%
1yr-71.09%
Volume Change (%)
10d/3m+7.85%
Price vs... (%)
52w High-69.72%
50d MA-27.56%
200d MA-49.85%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital16.02%
Return on Equity14.13%
Operating Margin20.05%

Financial Summary

Year End 30th SepUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m16.418.2225.4929.9129.5242.9858.3222.32%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+1052.23+16.93+81.97+8.52-32.74-88.39n/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202430th Sep 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Bon Natural Life EPS forecast chart

Profile Summary

Bon Natural Life Ltd is a China-based company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

Directors

    Last Annual
    September 30th, 2023
    Last Interim
    September 30th, 2023
    Incorporated
    December 11th, 2019
    Public Since
    June 24th, 2021
    No. of Shareholders
    16
    No. of Employees
    96
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    3,970,558

    BON Share Price Performance

    Upcoming Events for BON

    Half Year 2024 Bon Natural Life Ltd Earnings Release

    Similar to BON

    Picture of 60 Degrees Pharmaceuticals logo

    60 Degrees Pharmaceuticals

    us flag iconNASDAQ Capital Market

    Picture of Aadi Bioscience logo

    Aadi Bioscience

    us flag iconNASDAQ Capital Market

    Picture of Acasti Pharma logo

    Acasti Pharma

    us flag iconNASDAQ Capital Market

    Picture of Agriforce Growing Systems logo

    Agriforce Growing Systems

    us flag iconNASDAQ Capital Market

    Picture of Aptorum logo

    Aptorum

    us flag iconNASDAQ Capital Market

    FAQ